Baker / Tisch Capital (GP), LLC Insider Trading $BCRX BIOCRYST PHARMACEUTICALS INC
Get free email notifications about insider trading for Baker / Tisch Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker / Tisch Capital (GP), LLC. Baker / Tisch Capital (GP), LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX).
Baker / Tisch Capital (GP), LLC in BIOCRYST PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker / Tisch Capital (GP), LLC: 10% Owner
Holdings: 17,241 shares
Current Value: $97,756
Latest Transaction: Jun 01 2009
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker / Tisch Capital (GP), LLC in BIOCRYST PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, BCRX, GHDX, INCY, NRGN, SGEN, GEVA, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 3.89 | 835 | 3,244 | 17,241 | 18.1 K to 17.2 K (-4.62 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 3.86 | 2,157 | 8,335 | 18,076 | 20.2 K to 18.1 K (-10.66 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 4.12 | 2,065 | 8,514 | 20,233 | 22.3 K to 20.2 K (-9.26 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 4.30 | 402 | 1,729 | 22,298 | 22.7 K to 22.3 K (-1.77 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 4.50 | 2,975 | 13,400 | 22,700 | 25.7 K to 22.7 K (-11.59 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 4.45 | 1,651 | 7,353 | 25,675 | 27.3 K to 25.7 K (-6.04 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 0.98 | 49 | 48 | 27,326 | 27.3 K to 27.3 K (+0.18 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 0.91 | 207 | 189 | 27,277 | 27.1 K to 27.3 K (+0.76 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 1.00 | 2,028 | 2,028 | 27,070 | 25 K to 27.1 K (+8.10 %) |
Page: 1